Vevey, Switzerland

Katrien Claes

This inventor holds 1 USPTO granted patent. Top assignee: Lonza Inc.. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Katrien Claes in Protein Production

Introduction

Katrien Claes is an accomplished inventor based in Vevey, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the area of protein production. Her innovative work has led to the development of a patented technology that enhances the efficiency of producing proteins of interest.

Latest Patents

Katrien Claes holds a patent for a "Host cell for producing a protein of interest." This invention involves a eukaryotic host cell that has been genetically engineered to produce a heterologous protein of interest (POI). The host cell is modified to reduce the production of at least one of three different endogenous host cell proteins (HCP). This technology is crucial for improving the methods used in producing the POI, making it a valuable asset in the biotechnology industry.

Career Highlights

Katrien is currently employed at Lonza Inc., a leading global provider of integrated healthcare solutions. Her role at Lonza allows her to apply her expertise in biotechnology and contribute to advancements in protein production technologies.

Collaborations

Throughout her career, Katrien has collaborated with notable colleagues, including Christoph Kiziak and James Graham. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Katrien Claes is a pioneering inventor whose work in protein production has the potential to transform the biotechnology landscape. Her patented technology and collaborations with esteemed colleagues highlight her commitment to advancing scientific research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…